Regulation & Policy (Pharma & Healthcare)


Publication Single User License (PDF) Price
Opioids Market Overview to 2023 - Opioids in Western Europe

Opioids Market Overview to 2023 - Opioids in Western Europe

Date Published: Oct 31 2014

Opioids Market Overview to 2023 - Opioids in Western Europe report provides an estimation of 2013 opioid revenues and forecast consumption and revenues until 2023 in the five major Western European countries: the UK, Germany, France, Italy and Spain. The estimated revenues for 2013 are highest in the UK, which held a share of 52%, followed by Germany with 20%. Spain had the lowest in terms of both consumption (3.3%) and revenues (2.2%).

$2,995.00
Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China: From Regulations to Practices (2014 Edition)

Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China: From Regulations to Practices (2014 Edition)

Date Published: Oct 15 2014
$1,495.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

Date Published: Oct 1 2014
$1,995.00
Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)

Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)

Date Published: Sep 28 2014
China’s regulatory framework for in-vitro diagnostic reagents is undergoing earthshaking changes.
Chinese in-vitro diagnostic reagent market is likely to surpass 5.5 billion US dollars until 2015
$1,495.00
Ticagrelor  - Comprehensive patent search

Ticagrelor - Comprehensive patent search

Date Published: Sep 16 2014

Ticagrelor - Comprehensive patent search Prevention of thrombotic events in a patient with acute coronary syndromes, optionally in combination with Aspirin AstraZeneca (Brilinta, Possia, Brilique)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Fosaprepitant  - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Date Published: Sep 16 2014

Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Prevention of chemotherapy induced nausea and vomiting (CINV) in combination with Dexamethasone and/or other antiemetic agents, preferably 5-HT3 antagonist Merck (Emend, Ivemend, Emend IV)

$1,400.00
Mipomersen  - Comprehensive patent search

Mipomersen - Comprehensive patent search

Date Published: Sep 16 2014

Mipomersen - Comprehensive patent search Reduction of low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol in patients with homozygous familial hypercholesterolaemia, in combination with lipid-lowering drugs Genzyme (Kynamro)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Aprepitant  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Aprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Sep 16 2014

Aprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Prevention of chemotherapy induced nausea and vomiting (CINV) in combination with Dexamethasone and other antiemetic agents including 5-HT3 antagonist; Prevention of postoperative nausea and vomiting (PONV) Merck (Emend)

$600.00
Paliperidone  - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Date Published: Sep 16 2014

Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Treatment of schizophrenia, optionally in combination with antidepressants and/or mood stabilisers, preferably lithium or Valproate Janssen (Invega, Invega Sustenna); Johnson & Johnson (Invega Sustenna)

$1,400.00
Denosumab  - Comprehensive patent search

Denosumab - Comprehensive patent search

Date Published: Sep 16 2014

Denosumab - Comprehensive patent search Treatment to increase bone mass in men with osteoporosis at high risk for fracture; prevention of skeletal related events in patients with bone metastases from solid tumours; treatment of giant cell tumour of bone or skeletally mature adolescents that is recurrent, or unresectable, or resectable but associated with severe morbidity; reduction of the risk of vertebral, non-vertebral and hip fractures; treatment of postmenopausal women with osteoporosis at high risk for fracture; treatment to increase bone mass in men with nonmetastatic prostate cancer

$9,300.00
Enzalutamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Sep 16 2014

Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Treatment of metastatic castration-resistant prostate cancer Medivation (MDV3100); Astellas Pharma (Xtandi)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

$600.00
Ticagrelor  - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Ticagrelor - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Date Published: Sep 16 2014

Ticagrelor - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Prevention of thrombotic events in a patient with acute coronary syndromes, optionally in combination with Aspirin AstraZeneca (Brilinta, Possia, Brilique)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

$1,400.00
Elvitegravir  - Comprehensive patent search

Elvitegravir - Comprehensive patent search

Date Published: Sep 16 2014

Elvitegravir - Comprehensive patent search Treatment of HIV-1 infection in combination with Cobicistat, Emtricitabine and Tenofovir disoproxil fumarate, or Ritonavir-boosted protease inhibitors or other antiretrovirals Gilead (Stribild); Gilead (Vitekta); Japan Tobacco (Vitekta)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Fosaprepitant  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Sep 16 2014

Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Prevention of chemotherapy induced nausea and vomiting (CINV) in combination with Dexamethasone and/or other antiemetic agents, preferably 5-HT3 antagonist Merck (Emend, Ivemend, Emend IV)

$600.00
Simeprevir  - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Simeprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Date Published: Sep 16 2014

Simeprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Treatment of chronic hepatitis C infection in combination with Peginterferon alfa and Ribavirin, or with Sofosbuvir and optionally Ribavirin Janssen Pharm (Olysio, Galexos)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

$1,400.00
Ledipasvir  - Comprehensive patent search

Ledipasvir - Comprehensive patent search

Date Published: Sep 16 2014

Ledipasvir - Comprehensive patent search Treatment of chronic HCV infection in combination with Sofosbuvir Gilead

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Paliperidone  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Sep 16 2014

Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Treatment of schizophrenia, optionally in combination with antidepressants and/or mood stabilisers, preferably lithium or Valproate Janssen (Invega, Invega Sustenna); Johnson & Johnson (Invega Sustenna)

$600.00
Elvitegravir  - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Date Published: Sep 16 2014

Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Treatment of HIV-1 infection in combination with Cobicistat, Emtricitabine and Tenofovir disoproxil fumarate, or Ritonavir-boosted protease inhibitors or other antiretrovirals Gilead (Stribild); Gilead (Vitekta); Japan Tobacco (Vitekta)

$1,400.00
Exenatide  - Comprehensive patent search

Exenatide - Comprehensive patent search

Date Published: Sep 16 2014

Exenatide - Comprehensive patent search Treatment of type 2 diabetes mellitus optionally in combination with Metformin and/or, a sulfonylurea or a thiazolidinedione; or as adjunctive therapy to basal insulin optionally in combination with Metformin and/or Pioglitazone; in adults who have not achieved adequate glycaemic control Amylin (Byetta, Bydureon); Bristol-Myers Squibb (Byetta, Bydureon)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Tolvaptan  - Comprehensive patent search

Tolvaptan - Comprehensive patent search

Date Published: Sep 16 2014

Tolvaptan - Comprehensive patent search Treatment of hypervolemic and euvolemic hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion and congestive heart failure Otsuka Pharm (Samsca); Aspen (Samsca)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data